Profit Or Loss [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166143

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
2,087,000 EUR
900,000 EUR
Profit (loss) from operating activities
15,993,000 EUR
11,638,000 EUR
Finance income
898,000 EUR
466,000 EUR
Finance costs
285,000 EUR
730,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
147,000 EUR
130,000 EUR
Profit (loss) before tax
15,380,000 EUR
11,901,000 EUR
Tax expense (income)
- EUR
4,000 EUR
Profit (loss)
15,380,000 EUR
11,906,000 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
15,380,000 EUR
11,906,000 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.55
0.43

Talk to a Data Expert

Have a question? We'll get back to you promptly.